Siga Technologies

Pharma

Siga's Tpoxx misses the mark in mpox study amid renewed outbreak

Despite missing the primary endpoint of time to lesion resolution, the study offers clarity on patient groups who can most benefit from the treatment.

Zoey Becker Aug 15, 2024 11:35am

US renews $113M deal with Siga to supply mpox antiviral Tpoxx

Jul 19, 2024 10:35am

Siga snares $138M US government contract to supply smallpox drug

Jul 31, 2023 10:41am

FDA says overuse of Siga's Tpoxx could render it ineffective

Sep 15, 2022 10:54am

U.S. lines up AmerisourceBergen for monkeypox meds

Sep 7, 2022 9:04am

US adds monkeypox meds while Bavarian Nordic ups capacity

Aug 18, 2022 4:40pm